To help patients, you must understand what is standing in the way of them accessing the investigational drugs they wish to try.
from Forbes Real Time http://www.forbes.com/sites/arthurcaplan/2017/07/06/the-fda-is-the-most-important-part-of-compassionate-use/
via IFTTT
No comments:
Post a Comment